Cover Image

Eczema craquelé associated with antiviral treatment for chronic hepatitis C

Saved in:

Bibliographic Details
Main Authors:	Edla Polsinelli Bedin Mascarin do Vale (Author), Carlos Henrique Lima Rodrigues (Author), Fábio Esper Kallas (Author), Patricia da Silva Fucuta (Author)
Format:	Book
Published:	Sociedade Brasileira de Dermatologia, 2017-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
by: Akihiro Tamori, et al.
Published: (2016)

Effect of Helicobacter pylori Eradication on TLR2 and TLR4 Expression in Patients with Gastric Lesions
by: Aline Cristina Targa Cadamuro, et al.
Published: (2015)

EFFECTIVENESS OF ANTIVIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C IN CHILDREN
by: A.S. Potapov, et al.
Published: (2009)

EFFECTIVENESS OF ANTIVIRAL THERAPY OF CHRONIC VIRAL HEPATITIS C IN CHILDREN
by: A.S. Potapov, et al.
Published: (2009)

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
by: Suk-Jin Hong, et al.
Published: (2020)

Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
by: Roberto Focaccia, et al.
Published: (2015)

Health-related quality of life in patients with chronic hepatitis C during combined antiviral therapy
by: V. L. Rozina, et al.
Published: (2019)

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
by: Mohamed M Sakr, et al.
Published: (2019)

Intelligent MONitoring System for antiviral pharmacotherapy in patients with chronic hepatitis C (SiMON-VC)
by: Luis Margusino-Framiñán, et al.
Published: (2017)

Direct-acting antivirals for chronic Hepatitis C are effective and safe: an observational study in Londrina/PR
by: Hodnei Takashi Machado, et al.
Published: (2022)

How to compare antivirals in the treatment of chronic hepatitis B?
by: Leblebicioglu Hakan, et al.
Published: (2009)

Dependence of changes in hematological and integrative parameters in patients with chronic viral hepatitis C on the received antiviral therapy
by: A. H. Lishnevska, et al.
Published: (2020)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: MA Simón, et al.
Published: (2021)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
by: Tony Antoniou, et al.
Published: (2023)

Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
by: H. V. Venytska, et al.
Published: (2022)

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients
by: Nageh Ahmed El-Mahdy, et al.
Published: (2023)

Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
by: Lin Fan, et al.
Published: (2014)

The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
by: Hans Ludger Tillmann
Published: (2008)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018)

Combination of Direct Antiviral Therapy in Hepatitis C Patients, Population of Karachi
by: Samia Perwaiz Khan, et al.
Published: (2020)

Poliserositis in a patient with hepatitis C under treatment with new antivirals
by: Marina Lombardero Pin, et al.
Published: (2016)

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
by: Tony Antoniou, et al.
Published: (2023)

Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents
by: Pin-Nan Cheng, et al.
Published: (2023)

The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection
by: Dalia A Freekh, et al.
Published: (2021)

High efficacy and safety of direct‐acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam
by: Thong Duy Vo, et al.
Published: (2024)

Impact of direct acting antiviral agents on kidney function in hepatitis C virus infected patients with chronic kidney disease
by: Wedad Adel Mahmoud, et al.
Published: (2021)

Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients
by: Esther Granot, et al.
Published: (2001)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
by: Kerui Xu, et al.
Published: (2018)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
by: Ahmed El-Ghandour, et al.
Published: (2023)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011)

Peripheral blood mononuclear cells hepatitis C virus RNA as a predictor for the response to daclatasvir-containing oral antiviral regimen in chronic hepatitis C patients from the Damietta Governorate
by: Alaa E Hashim, et al.
Published: (2019)

New antivirals for hepatitis B
by: Vicente Soriano
Published: (2018)

CHANGES IN PHYSICAL AND CHEMICAL PROPERTIES OF ORAL FLUID IN PATIENTS WITH PERIODONTAL DISEASES IN THE SETTINGS OF CHRONIC HEPATITIS C DURING ANTIVIRAL THERAPY
by: H.A. Sichkoriz, et al.
Published: (2016)

DAA - directly acting antivirals - as a new, more efficient solution of the chronic hepatitis C treatment and theirs various application.
by: Kamila Abram, et al.
Published: (2023)

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study
by: Yu Fang, et al.
Published: (2023)

Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs
by: Amira Isaac, et al.
Published: (2021)